Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ric Treble

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Neuropharmacology|January 25, 2014
Designer psychostimulants: pharmacology and differencesLeslie Iversen, Michael White, Ric Treble
Drug Testing and Analysis|July 12, 2011
Reference materials for new psychoactive substancesRoland P Archer, Ric Treble, Keith Williams
Frontiers in Pharmacology|February 16, 2026
Legislating novel psychoactive substances: lessons from 15 years of UK mortality data (2007-2022)Kirsten L Rock, Ric Treble, Caroline S Copeland
Journal of Analytical Toxicology|March 5, 2022
The First Fatal Intoxication with 3-MeO-PCP in the UK and a Review of the LiteratureCaroline S Copeland, Simon Hudson, Ric Treble, et al.
European Journal of Pharmacology|December 25, 2012
Neurochemical profiles of some novel psychoactive substancesLes Iversen, Simon Gibbons, Ric Treble, et al.
Journal of Forensic and Legal Medicine|May 26, 2023
The first drug-related death associated with xylazine use in the UK and EuropeKirsten L Rock, Alexander J Lawson, Joanne Duffy, et al.
Plos One|March 23, 2018
Correction: The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA ReceptorBryan L Roth, Simon Gibbons, Warunya Arunotayanun, et al.
Plos One|March 26, 2013
The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptorBryan L Roth, Simon Gibbons, Warunya Arunotayanun, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2013
An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'Warunya Arunotayanun, Jeffrey W Dalley, Xi-Ping Huang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Neuropharmacology|January 25, 2014
Designer psychostimulants: pharmacology and differencesLeslie Iversen, Michael White, Ric Treble
Drug Testing and Analysis|July 12, 2011
Reference materials for new psychoactive substancesRoland P Archer, Ric Treble, Keith Williams
Frontiers in Pharmacology|February 16, 2026
Legislating novel psychoactive substances: lessons from 15 years of UK mortality data (2007-2022)Kirsten L Rock, Ric Treble, Caroline S Copeland
Journal of Analytical Toxicology|March 5, 2022
The First Fatal Intoxication with 3-MeO-PCP in the UK and a Review of the LiteratureCaroline S Copeland, Simon Hudson, Ric Treble, et al.
European Journal of Pharmacology|December 25, 2012
Neurochemical profiles of some novel psychoactive substancesLes Iversen, Simon Gibbons, Ric Treble, et al.
Journal of Forensic and Legal Medicine|May 26, 2023
The first drug-related death associated with xylazine use in the UK and EuropeKirsten L Rock, Alexander J Lawson, Joanne Duffy, et al.
Plos One|March 23, 2018
Correction: The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA ReceptorBryan L Roth, Simon Gibbons, Warunya Arunotayanun, et al.
Plos One|March 26, 2013
The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptorBryan L Roth, Simon Gibbons, Warunya Arunotayanun, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2013
An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'Warunya Arunotayanun, Jeffrey W Dalley, Xi-Ping Huang, et al.
Pageof 1